Bruce Kneller (Tag Archives)
Subscribe to PricePlow's Newsletter and Bruce Kneller Alerts
Bruce Kneller Returns with His New Nootropic Ingredient | Episode #104
https://blog.priceplow.com/podcast/bruce-kneller-nootropic-104
Five years in the making, it’s the return of Bruce Kneller to the PricePlow Podcast! We last saw him in in 2018 in Episode #009 where he dosed us with his new Bruce-class nootropic.
Well, he’s finally back with a real update, and with some good news – the nootropic should be ready at […]
Continue Reading →
FDA Announcement on CBD: We Need Help from Congress
On January 26th, 2023, the FDA made a major announcement regarding CBD (Cannabidiol), coming after years of deliberation, debate, and discussion. The gist of the message:
“We need help from Congress!”
View this post on InstagramFDA to Congress: We need more tools!
In a press release titled […]
Continue Reading →
Bruce Kneller’s Patent-Pending Nootropic Ingredient Coming in 2024?
Are you ready to get “red pilled”?!
Perhaps the better question is,
What’s in a “red pill”?We don’t know much, but we do know this:
Three or more active ingredients totaling >100mg. All three are chemically related. None of the three are ‘PEA back-boned’.The components come from a group of compounds (consisting […]
Continue Reading →
A Day with Bruce Kneller: Giant Sports, Gaspari, Stimulants, CBD, and More | Episode #009
Note: This page and audio feed was published on July 26, 2019, 1.5 years after the interview. Much has happened since then, but Bruce’s new nootropic ingredient is still not on the market as of right now, as he still awaits the US Patent and Trademark Office.
In February of 2018, the legendary Bruce […]
Continue Reading →
The Supplement Industry 2017 Year in Review: The 10 Biggest Stories
2017 was one to remember. It was filled with incredible highs and lows that make it one of the most tumultuous years in recent memory. As 2018 dawns, we take a look back at the previous 365 days to recount some of the most notable headlines that caught everyone’s attention.
A year like no other[…]Continue Reading →
DMHA / 2-Aminoisoheptane / Octodrine: Stimulant in Dispute with FDA
Note: This article was originally published in early 2015 but was last updated in 2023 with legal updates regarding Hi-Tech Pharmaceuticals’ lawsuit against the FDA.
New year, new stimulant? You bet!
In the wake of the removal of other popular stimulants over the past few years, a battle has raged to fill the void left […]
Continue Reading →
Eria Jarensis Extract / N-phenethyl dimethylamine: Advanced PEA Stimulant
In the sports and active nutrition corner of the dietary supplement industry, cutting-edge brands and consumer alike are constantly on the hunt for the “next stimulant”. Something to safely take training and mood to the next level.
That next compound arrived in 2015 by way of N-Phenyldimethylamine or N,N-Dimethylphenethylamine, a constituent of Eria […]
Continue Reading →
Giant Sports Giant Keto Takes BHB Salts to the Next Level
The keto diet has been consistently trending for years thanks to the wild success it’s had with dieters where no other diet has worked. Keto diets are quite literally life-savers for certain individuals, such as the obese, the overly carb sensitive, and even bodybuilders who are in the final throes of their show prep.
But […]
Continue Reading →
Statement Regarding Lenny and Larry’s Complete Cookie Lawsuit
Important Update: This lawsuit has been settled! Subscribe to our YouTube channel and sign up for our Protein news alerts to get notified when it’s public – Lenny and Larry customers may have some cash coming back to them!
On February 28th, 2017, two Illinois citizens filed a class action lawsuit against Lenny & Larry’s […]
Continue Reading →
The 2016 FDA NDI Draft Guidance Document: How To Destroy The ENTIRE Dietary Supplement Industry in 102 Pages
Disclaimer: This article was co-authored by Bruce Kneller and Mike.
On August 12th 2016, the FDA published a new Draft Guidance Document for NDIs (New Dietary Ingredients), in the Federal Register. Since this document is 102 pages long, there is much to discuss.
TL;DRThe FDA’s proposal is nothing short of a multi-pronged attack […]
Continue Reading →
